Singh J, Rattan S. Role of PKC and RhoA/ROCK pathways in the spontaneous phasic activity in the rectal smooth muscle. Am J Physiol Gastrointest Liver Physiol 304: G723-G731, 2013. First published February 14, 2013 doi:10.1152/ajpgi.00473.2012.-The role of PKC and RhoA/ROCK pathways in the phasic activities in the rectal smooth muscles (RSM) in the basal state is not known. We examined this issue by determining the effects of PKC inhibitors (calphostin C and Gö-6850) and a ROCK inhibitor (Y-27632) on the slow-rate (ϳ3/min) and fast-rate (ϳ25/min) phasic activities. We also examined the corresponding signal transduction cascades and the PKC and ROCK enzymatic activities in the RSM in the basal state. PKC inhibition with calphostin C and Gö-6850 (10 Ϫ5 M) caused a significant decrease (ϳ25%) in slow-rate (but not fast-rate) phasic activity (monitored by frequency and amplitude of contractions) of the RSM. Conversely, ROCK inhibition with Y-27632 (10 Ϫ5 M) caused a significant decrease not only in slow-rate, but also fast-rate, phasic activity caused by ROCK inhibition in the RSM. Western blot analysis revealed that the PKC inhibition-induced decrease in RSM phasic activity was associated with decreases in PKC␣ translocation, phosphorylated (Thr 38 ) PKC-potentiated inhibitor (CPI-17), and phosphorylated (Thr 18 /Ser 19 ) 20-kDa myosin regulatory light chain. Conversely, decreases in the phasic activity in the RSM by ROCK inhibition were accompanied by the additional decrease in phosphorylated (Thr 696 ) myosin phosphatase target subunit 1. Data show that while PKC and RhoA/ROCK pathways play a significant role in slow-rate high-amplitude spontaneous phasic activity, only the RhoA/ ROCK pathway primarily mediates fast-rate low-amplitude phasic activity, in the RSM. Such knowledge is important in the understanding of the pathophysiology of large intestinal motility disorders. Relative contributions of the PKC vs. the RhoA/ROCK pathway in the phasic activity remain to be determined. smooth muscle; phasic activity; Rho kinase; protein kinase C; rectoanal incontinence FECAL INCONTINENCE affects ϳ10% of the adult US population (45) and is multifactorial (2, 28, 43). These factors are impairment of basal internal anal sphincter (IAS) tone and external anal sphincter, puborectalis, and colorectal smooth muscle compliance. Recently, significant data in intact IAS of humans and animals demonstrated that the predominant molecular regulatory mechanism for IAS tone is the RhoA/ROCK pathway over the PKC pathway (26, 30, 32) . However, little is known about the patterns of rectal smooth muscle (RSM) contractions and regulatory mechanisms of the RSM, especially in the basal state.
smooth muscle; phasic activity; Rho kinase; protein kinase C; rectoanal incontinence FECAL INCONTINENCE affects ϳ10% of the adult US population (45) and is multifactorial (2, 28, 43) . These factors are impairment of basal internal anal sphincter (IAS) tone and external anal sphincter, puborectalis, and colorectal smooth muscle compliance. Recently, significant data in intact IAS of humans and animals demonstrated that the predominant molecular regulatory mechanism for IAS tone is the RhoA/ROCK pathway over the PKC pathway (26, 30, 32) . However, little is known about the patterns of rectal smooth muscle (RSM) contractions and regulatory mechanisms of the RSM, especially in the basal state.
A good starting point would be analysis of the contractile patterns in the phasic activity in the RSM in the basal state (29, 30, 32) . In the gastrointestinal tract smooth muscle, spontaneous contractions vary from 3 min Ϫ1 (in the stomach) to 8 -12 min Ϫ1 (in the small and large intestine) (33) . However, there is limited literature on the characterization of spontaneous phasic activity in the RSM. Such analysis is important to determine the molecular mechanisms controlling different patterns of the phasic activities. Such phasic activity, however, should not be confused with the initial peak contraction routinely investigated in response to different agonists and electrical field stimulation (EFS) (11, 16, 22, 39) , shown to be mediated primarily via the Ca 2ϩ /calmodulin/myosin light chain (MLC) kinase (MLCK) pathway.
Knowledge of the regulatory control mechanisms for the phasic activity in the RSM is critical in understanding the large intestinal compliance factor for rectoanal incontinence (2, 28, 43) and a number of other gastrointestinal motility disorders (15) , such as inflammatory bowel disease, Hirschsprung's disease, and constipation. Such phasic activity in the RSM in synchrony with colonic activity may participate in the colorectal excitatory reflex (27) .
It is well known that contraction of smooth muscle is primarily mediated by phosphorylation of 20-kDa myosin regulatory light chain (MLC 20 ) , and the degree and duration of contraction depend on the balance between the activities of MLCK and MLC phosphatase (MLCP). Recent studies have shown that the small GTP-binding protein RhoA and associated kinase (ROCK) (29, 31, 39) and PKC (3, 23, 38, 44) play important roles in regulation of MLCP activity via Ca 2ϩ sensitization and, consequently, in contraction of the smooth muscles. Accordingly, the RhoA/ROCK pathway causes inactivation of MLCP via phosphorylation of the noncatalytic subunit of MLCP, whereas PKC activation inhibits MLCP via phosphorylation of PKC-potentiated inhibitor (CPI-17), the endogenous inhibitory protein of the catalytic subunit of MLCP (20) .
Examination of the effects of the selective PKC inhibitors calphostin C (13, 21, 36) and Gö-6850 (5, 42) and the ROCK inhibitor Y-27632 (9, 17, 31, 34) provides important tools to study the roles of PKC and RhoA/ROCK in the phasic activity of the RSM. Such functional studies will be combined in parallel with the enzymatic activity assays and the signal transduction studies [phosphorylated (Thr  696 ) Therefore, the purpose of the present investigation is to analyze the phasic motility pattern of the RSM and to investigate the roles of RhoA/ROCK and PKC pathways in the molecular control mechanisms.
MATERIALS AND METHODS
Tissue preparation. As previously described (30) , Sprague-Dawley rats (300 -350 g body wt) were killed by decapitation. The anal canal with an adjacent region of the RSM was quickly removed and transferred to oxygenated (95% O 2-5% CO2) Krebs physiological solution (KPS) of the following composition (in mM): 118.07 NaCl, 4.69 KCl, 2.52 CaCl2, 1.16 MgSO4 1.01 NaH2PO2, 25 NaHCO3, and 11.10 glucose (37°C). Extraneous adventitious blood vessels and skeletal muscle tissues connected to the anal canal were removed carefully by sharp dissection. The anal canal was then opened and pinned flat, with the mucosal side up, and mucosa was removed carefully by sharp dissection and divided into two distinct regions, the IAS and RSM. From the IAS and RSM, circular smooth muscle strips (1 ϫ 7 mm) were prepared. The experimental protocols of the study were approved by the Institutional Animal Care and Use Committee of Thomas Jefferson University and were carried out in accordance with the recommendations of the American Association for the Accreditation of Laboratory Animal Care.
Measurement of isometric tension. The smooth muscle strips were transferred to 2-ml muscle baths containing oxygenated KPS at 37°C. One end of the strips was anchored at the bottom of the muscle bath, and the other end was connected to a force transducer (FORT10, WPI, Sarasota, FL). Isometric tension was measured by the PowerLab 8SP data acquisition system (ADInstruments, Castle Hill, Australia) and recorded using Chart 4.1.2 (ADInstruments). Each smooth muscle strip was initially stretched to a tension of 1.0 g. The muscle strips were allowed to equilibrate for 1 h, during which they were washed with KPS every 20 min. The RSM developed spontaneous low-and high-frequency phasic activities superimposed on a low-grade tone, and such smooth muscles primarily responded by contraction to EFS (6) . Depending on the experimental protocol, we examined the effects of different concentrations (10 Ϫ8 -10 Ϫ4 M) of calphostin C, Gö-6850, and Y-27632 on the basal activity of the RSM.
PKC and ROCK activity. PKC and ROCK activity were measured in tissue homogenates of the RSM before and after treatment with different concentrations of inhibitors at 0, 2, 4, 6, 8, and 10 min. The smooth muscle tissue strips were flash-frozen using Wollenberger tongs precooled in liquid N2 (30) and homogenized in ice-cold lysis buffer consisting of 50 mM Tris·HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, a protease inhibitor mixture, and Na3VO4, a phosphatase inhibitor (Pierce Biotechnology, Rockford, IL). The protein concentration in tissue lysates was determined using a BCA protein assay kit (Pierce Biotechnology). Kinase activity was measured using nonradioactive kinase assay kits (catalog no. EKS-420, Assay Designs for PKC; catalog no. STA-416, Cell Biolabs). RSM tissue lysates were titrated to determine the optimal protein concentration for the final activity assay; 5-40 g were used for PKC activity assay, and 0.5-16 g were used for ROCK activity assay. PKC and ROCK activities in tissue lysates were calculated on the basis of PKC and ROCK standard concentration curves using specific 450-nm absorbance according to the manufacturer's instructions. All samples were assayed in quadruplicate, and the ELISA was performed twice.
Tissue lysate preparation and Western blot analysis. While the isometric tension was monitored, the RSM strips were quick-frozen before and after pretreatment with calphostin C, Gö-6850, and Y-27632. Once the response to these inhibitors reached a plateau, the tissue chambers were rapidly lowered, exposing the tissues, which were quickly snap-frozen, as described above. The tissue samples were cut into small pieces (ϳ1-mm cubes) and homogenized on ice in buffer (1% SDS, 1.0 mM Na3VO4, and 10 mM Tris, pH 7.4) using a volume equal to five times the tissue weight. The homogenates were centrifuged (14,000 rpm) for 5 min, and the supernatants were collected. The protein concentration in the supernatants was determined using a BCA protein assay reagent kit, with BSA used as a standard (Pierce Biotechnology) (19) . Twenty micrograms of protein in 20 l of lysates were mixed with 2ϫ Laemmli sample buffer (with final concentrations of 62.5 mM Tris, 1% SDS, 15% glycerol, 0.005% bromophenol blue, and 2% ␤-mercaptoethanol) and placed in a boiling water bath for 5 min. Proteins in the samples were separated by SDS-polyacrylamide gel [ Data analysis. All the calculations for force experiments were done using GraphPad Prism 5.3. Values are means Ϯ SE. Relative densities of Western blots were calculated using ImageJ software (National Institutes of Health) and normalized to 1. One-way ANOVA followed by a Bonferroni's post hoc test was used (P Ͻ 0.05) to calculate statistical significance.
RESULTS
Inhibition of PKC activity by calphostin C. PKC activity data revealed that, in the basal state, maximal PKC activity in RSM and IAS tissues was observed with 30 g of the tissue lysates (n ϭ 4; Fig. 1A ). The PKC inhibitor calphostin C (10 Ϫ5 M) caused a time-dependent decrease in PKC activity that was nearly obliterated within 8 min of administration (Fig. 1B) . The specificity of the effect of calphostin C was further evident from the data that this inhibitor, in contrast to the ROCK inhibitor Y-27632, caused a significant and concentrationdependent decrease in PKC activity in tissue lysates (P Ͻ 0.05, n ϭ 4; Fig. 1C ). Figure 1D Note that the PKC inhibitor calphostin C has no effect on rate or amplitude (P Ͼ 0.05, n ϭ 5), while Gö-6850 also has no significant effect on rate (P Ͼ 0.05, n ϭ 5) but causes a small, but significant, decrease in amplitude (*P Ͻ 0.05).
10
Ϫ8 -10 Ϫ4 M calphostin C; maximal inhibition was achieved in the presence of 10 Ϫ5 M calphostin C.
Comparison of ROCK activity levels in the IAS vs. RSM: influence of calphostin C vs. Y-27632.
Parallel data with ROCK activity in the RSM and IAS showed that the optimal concentration of the tissue lysates was 8 g (Fig. 2A) and that ROCK activity was significantly higher in the IAS than RSM (3.67 Ϯ 0.24 vs. 1.8 Ϯ 0.33 pmol/mg, P Ͻ 0.05, n ϭ 4; Fig. 2, A and  C) . The incubation required for maximal inhibition by Y-27632 was determined to be 8 min (Fig. 2B) . Data further revealed the specificity of the ROCK inhibitor (P Ͻ 0.05, n ϭ 4; Fig. 2C ), as calphostin C had no significant effect (P Ͼ 0.05; Fig. 2C) .
Influence of PKC and ROCK inhibitors on rate and amplitude of slow-rate phasic activity in the RSM. Frequency of contraction data in the IAS and RSM was analyzed using built-in software for the rate analysis (PowerLab, ADInstruments). Two main types of phasic activity were recorded in the RSM: slow-rate (2.7 Ϯ 0.09 min
Ϫ1
; Fig. 3A ) and fast-rate (25 Ϯ 1.4 min
; Fig. 4A ). A typical RSM force recording (Fig. 3B,  inset) shows that PKC inhibition with calphostin C or Gö-6850 caused significant inhibition of frequency (absolute and %max-imal; P Ͻ 0.05, n ϭ 5; Fig. 3 , A and B) and amplitude (P Ͻ 0.05, n ϭ 5; Fig. 3 , C and D) of slow-rate contractions in the RSM. Interestingly, Gö-6850 was more effective than calphostin C. Y-27632 also caused a concentration-dependent decrease in the rate and amplitude of slow-rate phasic activity of the RSM and was more effective than calphostin C and Gö-6850 (P Ͻ 0.01, n ϭ 5; Fig. 3 ). The maximal effective concentration of Gö-6850 (10 Ϫ5 M) caused a decrease in the rate and amplitude of 15% and 28%, respectively; in the case of Y-27632, these values were 40% and 53%, respectively.
Influence of PKC and ROCK inhibitors on rate and amplitude of fast-rate phasic activity in the RSM. In contrast to the slow-rate phasic activity, the fast-rate phasic activity frequency in the RSM was not affected by calphostin C or Gö-6850 (P Ͼ 005, n ϭ 5; Fig. 4, A and B) . Interestingly, unlike calphostin C, Gö-6850 caused a small, but significant, decrease in amplitude of the fast-rate phasic activity (P Ͻ 0.05; Fig. 4, C and D) . In sharp contrast, Y-27632 caused a substantial, significant, and concentration-dependent decrease in rate and amplitude of the fast-rate phasic activity in the RSM (n ϭ 5, P Ͻ 0.01; Fig. 4) .
As shown in Figs. 5 and 6, rate and amplitude of the slowand fast-rate phasic activity in the RSM were almost abolished by 0 Ca 2ϩ . Additionally, the data summarize the effects of maximally inhibitory concentrations of calphostin C, Gö-6850, Y-27632, and Y-27632 ϩ Gö-6850. The data show that, in inhibiting the slow-rate, as well the fast-rate, contraction in terms of rate and amplitude, Y-27632 caused significantly greater inhibition than calphostin C or Gö-6850 (P Ͻ 0.05). The data further reveal a further significant decrease in the amplitude of the slow-rate (n ϭ 5, P Ͻ 0.05; Fig. 5 ), but not fast-rate (n ϭ 5, P Ͼ 0.05; Fig. 6 ), phasic activity in the RSM by Y-27632 ϩ Gö-6850 compared with either inhibitor alone. These data suggest a role of PKC and RhoA/ROCK pathways in the slow rate of spontaneous activity and that the fast rate of activity in the RSM is primarily mediated by the RhoA/ROCK pathway.
Effect of the PKC activator phorbol 12,13-dibutyrate before and after calphostin C in the RSM. As shown in Fig. 7 , the significant and concentration-dependent increase in RSM contraction by phorbol 12,13-dibutyrate (PDBu) was blocked by the PKC inhibitor calphostin C (n ϭ 7, P Ͻ 0.05). These data suggest that the PDBu-stimulated increase in the phasic activity of the RSM is mediated by PKC.
Effect of PKC vs. ROCK inhibition on PKC translocation. Western blot data show higher basal levels of PKC␣ in the particulate than cytosolic fraction of the RSM (P Ͻ 0.05, n ϭ 4; Fig. 8 ). This trend was significantly reversed by the PKC inhibitors, and not by Y-27632 (P Ͼ 0.05). These data further show the selective effects of calphostin C and Gö-6850 on PKC activation. 20 in the RSM were decreased significantly by calphostin C and Gö-6850 and further decreased significantly by Y-27632 (P Ͻ 0.05; Fig. 9, A and  C) . In contrast, however, the basal levels of phosphorylated (Thr 696 ) MYPT1 were also significantly decreased by Y-27632 (P Ͻ 0.05; Fig. 9 ). These changes in the signal transduction cascade following pretreatment with the PKC-and ROCKselective inhibitors suggest convergence of PKC and RhoA/ ROCK on phosphorylated ( of studies have shown that basal tone in the lower esophageal sphincter and IAS in humans and animals is mediated primarily via the RhoA/ROCK pathway (25, 30, 32, 37) .] The present data also show selectivity of the effects of PKC and ROCK inhibitors on the respective pathways. Additionally, these studies suggest that PKC activation via phosphorylated CPI-17/ phosphorylated MLC 20 and RhoA/ROCK activation via phosphorylated CPI-17/phosphorylated MYPT1/phosphorylated MLC 20 is the primary mechanism for the phasic activity in the RSM. A direct link, however, between these pathways and the subsequent signal transduction remains to be established.
Effect of calphostin C and Y-27632 on phosphorylated (Thr
The present studies suggest that the RSM serves as an important model for examination of molecular control mechanisms for spontaneous phasic activity in the gastrointestinal tract. On the basis of the automated analysis, spontaneous phasic activity in the RSM was broadly classified as slow (ϳ3 min
Ϫ1
) and fast (ϳ25 min Ϫ1 ). Furthermore, the slow-rate phasic activity has high amplitude (ϳ250 mg), and the highrate phasic activity has low amplitude (ϳ55 mg). The diverse rates of the phasic activity in the RSM have been previously reported in the large intestine (33, 40, 41) and have been grouped as second and minute rhythms in the smooth muscles (10) .
The evidence that PKC and RhoA/ROCK pathways play a major role in the slow-rate spontaneous phasic activity is based on the significant decrease in the rate and amplitude of such phasic activity following PKC and ROCK inhibition. The PKC-and RhoA/ROCK-mediated signal transduction associated with the slow-rate phasic activity in the RSM is mediated by phosphorylated CPI-17/phosphorylated MLC 20 and phosphorylated CPI-17/phosphorylated MYPT1/phosphorylated MLC 20 , respectively. This is evident by the simultaneous decrease in membrane translocation of PKC␣ and ROCK II (data not shown) and the corresponding decreases in phosphorylated CPI-17/phosphorylated MLC 20 and phosphorylated CPI-17/phosphorylated MYPT1/phosphorylated MLC 20 , respectively. The nature of this signal transduction cascade involving PKC and RhoA/ROCK in the mediation of RSM contractility is in agreement with earlier data that showed that RhoA/ROCK-mediated Ca 2ϩ sensitization responsible for the smooth muscle contraction occurs via phosphorylated MYPT1, as well as phosphorylated CPI-17 (20, 23, 29, 39) . On the other hand, smooth muscle contraction induced by the PKC pathway is associated with phosphorylation of CPI-17, an endogenous inhibitor of MLCP (8, 23) . The role of PKC in the stimulated phasic activity in the RSM is shown by an increase in the contractile activity of the RSM by PDBu that is inhibited by calphostin C. Interestingly, in opossum IAS smooth muscle, PDBu causes relaxation (4), instead of contraction, as observed here in rat RSM.
The combined inhibition of PKC and RhoA/ROCK pathways causes further inhibition of the phasic activity, which is more than the sum of individual inhibitions. The data suggest that these pathways, in major part, work in parallel, and since the predominant pathway is RhoA/ROCK, it remains to be determined whether part of the PKC role is mediated via RhoA/ROCK activation, as suggested previously (18, 24) . Furthermore, it has been shown that agonist-mediated phasic contraction of the smooth muscle may not only be tissuespecific, but also species-specific (35), as carbachol-mediated contraction was significantly blocked by the ROCK inhibitor Y-27632 in rat, but not guinea pig, urinary bladder smooth muscle.
Residual phasic activity following the combined inhibition of these pathways suggests that a portion of RSM phasic activity may be independent of PKC and RhoA/ROCK. This may not be explained on the basis of insufficient PKC and RhoA/ROCK inhibition, because these inhibitors in the concentrations used nearly obliterated their respective enzymatic activities. Additionally, similar data were obtained with the combination of PKC and ROCK inhibitors.
The role of PKC mediation in the slow-rate phasic activity in the RSM is supported by differential signal transduction studies as follows. In contrast to the basal tone in human and cat lower esophageal sphincter, ACh-and EFS-induced phasic contraction in the esophageal body is primarily mediated by PKC (12, 25, 37) . Similar conclusions were drawn by the inhibition of carbachol-induced contraction of urinary bladder by PKC inhibitor (7) . Additionally, a number of studies have shown that agonist-induced smooth muscle contraction involves not only PKC, but also RhoA/ROCK, pathways (1, 23, 35) . The present data suggest that, in the RSM, the RhoA/ ROCK pathway plays a dominant role in the slow-rate, as well as the fast-rate, phasic activity, as shown by a dramatic decrease in the rate and amplitude of these contractile activities following selective ROCK inhibition.
These data lead to the speculation that PKC and RhoA/ ROCK pathways work cooperatively in the slow-rate phasic activity in the RSM, while the RhoA/ROCK pathway is critical in the fast-rate phasic activity. The critical role of the RhoA/ ROCK pathway in the fast-rate low-amplitude phasic activity in the RSM is shown by selective and substantial inhibition of such spontaneous phasic activity by ROCK, but not by PKC. Such data are in agreement with recent studies in human myometrium, where it was shown that certain phasic activity is mediated primarily via the RhoA/ROCK pathway (14) .
In conclusion, the spontaneous phasic activity in the RSM occurs in two forms: slow-rate high-amplitude and fast-rate low-amplitude. The slow-rate phasic activity is mediated cooperatively via the PKC and RhoA/ROCK pathways, whereas the fast-rate phasic activity is mediated primarily via the RhoA/ROCK pathway. Relative contributions of these pathways and the possibility of interaction between the two remain to be determined. Systematic investigation of the molecular control mechanisms responsible for the rate and amplitude of the spontaneous phasic activity in the RSM provides an important model for the pathophysiological changes in gastrointestinal smooth muscle without the need for an agonist. 
